Helix Acquisition Corp
Why Robinhood?
You can watch HLXB and buy or sell other stocks, ETFs, and their options commission-free!About HLXB
Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies.
HLXB Key Statistics
Stock Snapshot
With a market cap of 793.14M, Helix Acquisition Corp(HLXB) trades at $9.90. The stock has a price-to-earnings ratio of -0.01.
On 2026-09-08, Helix Acquisition Corp(HLXB) stock opened at —, reached a high of —, and a low of —.
The Helix Acquisition Corp(HLXB)'s current trading volume is 0, compared to an average daily volume of 248.18K.
In the last year, Helix Acquisition Corp(HLXB) shares hit a 52-week high of $14.87 and a 52-week low of $7.00.
In the last year, Helix Acquisition Corp(HLXB) shares hit a 52-week high of $14.87 and a 52-week low of $7.00.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.